Smith & Nephew Publishes Q3 2026 Trading Update Transcript

By Public Technologies
  • Smith & Nephew cut its 2026 underlying revenue growth forecast to approximately 3%, reflecting weak US knees and hips performance.
  • At the November 4 third-quarter trading update, CEO Deepak Nath and interim CFO Pierre Palassian reported 3.4% underlying revenue growth.
  • Full-year trading profit is now forecast at around USD 1.25 billion, with free cash flow of approximately USD 750 million.
  • Discussions with J&J over a DePuy Synthes combination have ended; management continues actively exploring the full range of strategic options for Orthopaedics.
  • LANDMARK's cemented knee version is expected in the second quarter of 2027, with meaningful commercial traction anticipated in the second half.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Smith & Nephew plc published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.